Drugmaker Agrees To Stop Selling Unapproved Skin Drugs

Law360, New York (March 2, 2017, 4:28 PM EST) -- Crown Laboratories Inc. has agreed to stop selling several creams and lotions for various skin conditions, including eczema, psoriasis and acne, without U.S. Food and Drug Administration approval, according to a Wednesday filing in Tennessee federal court.

The federal government hit the drug manufacturer and CEO Jeffrey Bedard with a complaint Wednesday seeking an injunction to stop them from making and selling prescription urea cream and lotion, as well as sodium sulfacetamide lotion, claiming that Crown hasn’t sought FDA approval for these products and deeming them...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

United States of America v. Crown Laboratories, Inc. et al


Case Number

2:17-cv-00036

Court

Tennessee Eastern

Nature of Suit

Other Statutory Actions

Judge

Curtis L Collier

Date Filed

March 1, 2017

Law Firms

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.